Growth Metrics

Travere Therapeutics (TVTX) Profit After Tax (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -68.75%
Dec 31, 2025 -185.53%
Sep 30, 2025 301.54%
Jun 30, 2025 69.06%
Mar 31, 2025 31.60%
Dec 31, 2024 -10.07%
Sep 30, 2024 22.24%
Jun 30, 2024 48.25%
Mar 31, 2024 -50.89%
Dec 31, 2023 -159.82%
Sep 30, 2023 247.88%
Jun 30, 2023 -18.07%
Mar 31, 2023 -0.81%
Dec 31, 2022 -1.87%
Sep 30, 2022 -25.41%
Jun 30, 2022 18.00%
Mar 31, 2022 -58.51%
Dec 31, 2021 -44.71%
Sep 30, 2021 8.65%
Jun 30, 2021 27.58%
Mar 31, 2021 55.71%
Dec 31, 2020 -439.37%
Sep 30, 2020 13.50%
Jun 30, 2020 -3,326.24%
Mar 31, 2020 102.67%
Dec 31, 2019 17.08%
Sep 30, 2019 5.71%
Jun 30, 2019 5.55%
Mar 31, 2019 -449.66%
Dec 31, 2018 86.33%
Sep 30, 2018 -144.15%
Jun 30, 2018 -21.50%
Mar 31, 2018 -4.31%
Dec 31, 2017 0.99%
Sep 30, 2017 -34.51%
Jun 30, 2017 -19.29%
Mar 31, 2017 -28.91%
Dec 31, 2016 76.82%
Sep 30, 2016 -176.90%
Jun 30, 2016 -219.50%
Mar 31, 2016 554.27%
Dec 31, 2015 -102.34%
Sep 30, 2015 513.59%
Jun 30, 2015 -164.37%
Mar 31, 2015 236.61%
Dec 31, 2014 -61.44%
Sep 30, 2014 -252.31%
Jun 30, 2014 115.59%
Mar 31, 2014 -501.46%
Dec 31, 2013 -4.84%
Sep 30, 2013 -133.05%
Jun 30, 2013 -8.69%
Nov 30, 2012 -12,203,233.33%
Aug 31, 2012 100.00%
Nov 30, 2011 0.20%